YasminHKarimiMD

PubMed

• Divergent paths: management of early relapsed follicular lymphoma.
  Radhika Takiar, Yasmin Karimi, Tycel J Phillips> ;Hematology. American Society of Hematology. Education Program. 2022 Dec 9
• 1 citations
  Novel Salvage Therapy Options for Initial Treatment of Relapsed/Refractory Classical Hodgkin's Lymphoma: So Many Options, How to Choose?
  Radhika Takiar, Yasmin Karimi> ;Cancers. 2022 Jul 20
• 2 citations
  Development and Use of Natural Language Processing for Identification of Distant Cancer Recurrence and Sites of Distant Recurrence Using Unstructured Electronic Health...
  Yasmin Karimi, Douglas W. Blayney, Allison W. Kurian, Jeanne Shen, Rikiya Yamashita, Daniel L. Rubin, Imon Banerjee> ;JCO Clinical Cancer Informatics. 2021 Apr 30
• 1 citations
  Targeted Therapies for Follicular Lymphoma
  Jennifer Girard, Yasmin Karimi, Shannon A. Carty, Ryan A. Wilcox, Mark S. Kaminiski, Sami N. Malek, Tycel Phillips> ;Current Hematologic Malignancy Reports. 2021 Feb 1
• 4 citations
  A phase 1 study of azacitidine with high-dose cytarabine and mitoxantrone in high-risk acute myeloid leukemia.
  Kirk E. Cahill, Yasmin H. Karimi, Theodore Karrison, Nitin Jain, Margaret Green, Howard L. Weiner, Noreen Fulton, Sabah Kadri, Lucy A. Godley, Andrew S. Artz, Hongtao ...> ;Blood Advances. 2020 Feb 25
• Join now to see all

Lectures

• Real-world efficacy of bone modifying agents (BMAs) in patients with breast cancer (BC) treated in an academic health system: Use of the “green button. 
  2019 ASCO Annual Meeting - 6/1/2019